Semax + Selank blend user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: Semax + Selank blend dosage in studies.

In short

Of 54 people, 29 (54%) said the Semax + Selank blend brought some benefit and 20 (37%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Peptides (20 accounts), r/Nootropics (19), r/Biohackers (14), r/Selank (2), r/Semax (2) and r/Retatrutide (1), 25 Nov 2024 to 8 Sep 2026. The posts were retrieved from a public Reddit archive. From first-person posts about the Semax + Selank blend, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 30/30 (100%). One post looked like marketing and is not in the figures.

Whose accounts these are: routes mentioned: nasal spray 13, injection 9; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did the Semax + Selank blend help? The overall picture

Of 54 people, 22 (41%) reported benefit only, 7 (13%) both benefit and harm, 13 (24%) harm only and 12 (22%) neither.

Stopping. 7 people (13%) said they stopped or paused: 2 because of harms and 5 because they noticed no effect or for another reason.

Share = people / 54.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only2241%
Both benefit and harm713%
Harm only1324%
Neither benefit nor harm1222%

Most common reported benefits

Of 54 people. 29 (54%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Alertness, energy or motivation1019%
Focus1019%
Less anxiety917%
Better mood36%
Better sleep36%
Social ease24%
Memory12%
Other benefit1426%

Share = people / 54.

Most common reported harms

Of 54 people. 20 (37%) mentioned some harm; 2 said explicitly they had none.

ReportedPeopleShare
Anxiety, irritability or overstimulation713%
Insomnia59%
Fatigue or crash47%
Emotional blunting or low mood47%
Nasal irritation or nosebleed36%
Heart or blood pressure24%
Brain fog12%
Libido12%
Other, rarer harm815%

Share = people / 54.

How severe were the harms?

Of the 20 people who described how strong a harm was, 15 (75%) described it as mild, 5 (25%) as clearly bothersome and 0 (0%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 20.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable1575%
Clearly bothersome: several days, sleep or work affected525%
Severe: emergency visit, hospital or unable to function00%

Harms known from research and regulators: What are the harms of the Semax + Selank blend?

How long did people use the Semax + Selank blend?

25 of 54 people (46%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 25.
Stated length of usePeopleShare
Under a week1248%
1-4 weeks1040%
1-3 months312%
Over 3 months00%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

26 of 54 people (48%) used other substances at the same time. The most common: retatrutide (14), NAD+ (8) and GHK-Cu (6). Then the account cannot tell which substance had the effect.

Two substances together, not single substances

We counted accounts in which the writer used Semax and Selank together themselves: as a ready-made blend or as two substances at the same time. Accounts about only one of them are not included. The single substances have their own summaries: Semax user experiences and Selank user experiences. The summaries come from the same archive, so the same post can appear in more than one of them.

The 58 accounts came from 54 different people. The composition sellers declare and its gaps: Semax + Selank blend: what the research shows. The accounts cannot tell which of the two had an effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: Dosage of the Semax + Selank blend in studies. Legal status: Is the Semax + Selank blend legal in Finland?

What can be concluded?

The most common reported benefits were alertness, focus and less anxiety, but the most common harm was anxiety or irritability. Many noticed nothing, and of those who said how long they had used it, most had used it for less than a month.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: Semax + Selank blend: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Semax user experiences, Selank user experiences, DSIP user experiences, Noopept user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.